Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Classificação em ações #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Preço da ação
$0.1559364
Última sincronização: 2026-09-18
Valor de mercado
$195.17K
Variação (1 dia)
6.60%
Variação (1 ano)
-30.91%
País
GB
Negociar Fusion Antibodies plc (FAB)

Categoria

Receita da Fusion Antibodies plc (FAB)
Receita em Sep 2025 TTM: $2.15M
De acordo com os últimos relatórios financeiros da Fusion Antibodies plc, a receita atual da empresa (TTM) é $2.15M. Em 2024, a empresa obteve uma receita de $1.43M uma diminuição em relação a a receita do ano 2023, que foi de $3.58M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Fusion Antibodies plc de 2013 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $2.15M -15.49%
2025 $2.54M 77.00%
2024 $1.43M -59.95%
2023 $3.58M -43.24%
2022 $6.31M 9.89%
2021 $5.74M 18.80%
2020 $4.83M 70.09%
2019 $2.84M -24.66%
2018 $3.77M 57.07%
2017 $2.40M 12.81%
2016 $2.13M 57.86%
2015 $1.35M 11.90%
2014 $1.20M 95.78%
2013 $615.46K 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$12.62B 588,305.51%
US
$6.02B 280,545.95%
NL
$2.23B 103,744.77%
US
$15.74B 733,726.73%
AU
- -
CH